Robotic pelvic lymphadenectomy is a routine staging procedure performed at the time of robotic radical prostatectomy for men at risk for nodal metastases. The procedure is safe and reproducible with limited complications and provides important risk stratification information that helps stratify patients by risk of biochemical and clinical progression. Patients with limited lymph node metastases may do well after surgery alone and be observed closely. Those with higher volume lymph node metastases or N1 disease and biochemical recurrence may benefit from androgen deprivation therapy or radiation therapy or the combination.